Skip to main content
Fig. 8 | Journal of Experimental & Clinical Cancer Research

Fig. 8

From: Inhibition of retinoic acid receptor α phosphorylation represses the progression of triple-negative breast cancer via transactivating miR-3074-5p to target DHRS3

Fig. 8

CDK7 inhibitor THZ1 suppresses TNBC growth via RARαS77-DHRS3 signaling. a Western blotting analysis of RARα (p-Ser77) and RARα protein expression levels after treatment of THZ1 for 48 h. b TNBC cell viability was assessed after THZ1 treatment by MTT analysis and IC50 values were calculated. c qRT-PCR and western blotting analysis of DHRS3 levels after THZ1 treatment

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us